Brief: Vitrolife Q1 EBITDA Rises To SEK 228 Million
April 22 (Reuters) - Vitrolife AB VITR.ST :
* INTERIM REPORT JANUARY-MARCH 2022: BUILDING ON OUR STRONG
GROWTH
MOMENTUM
* Q1 SALES SEK 752 MILLION VERSUS SEK 379 MILLION YEAR AGO
* Q1 EBITDA SEK 228 MILLION VERSUS SEK 163 MILLION YEAR AGO
Source text for Eikon: ID:nWkrbxqqgn
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))